Systemic loxoscelism presented in a pregnant patient
Main Article Content
Keywords
Spider bites, Emergencies, Pregnancy, Antivenins
Abstract
Background: loxoscelism is a condition caused by the inoculation of a series of proteolytic enzymes through the loxosceles spider bite (violinist). Morbidity and mortality is unknown in our country. The loxoscelism toxi-syndrome of local expression may have a good prognosis; however, viscera-cutaneus or systemic form has a serious and often fatal evolution. We report a case of a systemic variant developed in a pregnant patient.
Clinical case: we present the first reported case of systemic loxoscelism in a pregnant patient, highlighting the survival of the mother-son, in the presence of viscera-cutaneus behavior. We describe the natural history of clinical expression, highlighting the benefit of current therapeutic antivenom fourth generation and immunoregulation role in supporting the therapeutic approach and the guideline of the surgical approach.
Conclusions: the appropriate multidisciplinary management coupled with an early use of antivenom limits the severity and the potential development of complications. Clinical suspicion is the cornerstone of therapeutic management of these patients.
References
Sams HH, Dunnick CA, Smith ML, King LE Jr. Necrotic arachnidism. J Am Acad Dermatol. 2001;44(4):5-73.
Álvarez-del Toro M. Las arañas de Chiapas. Tuxtla Gutiérrez, Chiapas: Universidad Autónoma de Chiapas; 1992.
Fernández-Barocio F, Sánchez-Villegas MCS. Epidemiología de las intoxicaciones en el servicio de urgencias pediátricas de un hospital de tercer nivel. Reporte de cinco años. Arch Med Urg Mex. 2013;5(1):18-24. Texto libre en http://www.medigraphic.com/pdfs/urgencia/aur-2013/aur131d.pdf
Cabrerizo S, Docampos PC, Cari C, Ortiz-de Rozas M, Díaz M, De Roodt A, et al. Loxoscelismo: epidemiologia y clínica de una patología endémica en el país. Arch Argent Pediatr. 2009;107(2):152-9.
Zaragoza-Fernández M, López-Ortiz R, Domínguez-Bueno E, Santos-Velasco J, Gaviro-Gómez M. Loxoscelismo cutáneo. Emergencias. 2008;20(1):64-7.
Hogan CJ, Barbaro KC, Winkel K. Loxoscelism: old obstacle, new directions. Ann Emerg Med. 2004;44
(6):608-24.
Olvera-Rodríguez A, Alagón-Cano A, Ramos-Cerrillo BM, Cardoso-Torres HM, Olvera-Rodríguez F. La partitura de la araña violinista: envenenamiento fatal. Hypatia [Internet]. 2007 abr-jun;(22):[aprox. 2 p.]. [Citado el 2 abril de 2013].
Gómez HF, Krywho DM, Stoecker WV. A new assay for the detection of Loxosceles species (brown recluse) spider venom. Ann Emerg Med. 2002;39 (5):469-74.
De Souza AL, Malaque CM, Sztajnbok J, Romano CC, Duarte AJ, Seguro AC. Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury. Toxicon. 2008;51(1):151-6.
Luciano MN, Da Silva PH, Chaim OM, Dos Santos VL, Franco CR, Soares MF, et al. Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in renal tissue. J Histochem Cytochem. 2004;52(4):455-67.
Berrón R, Espinosa F, Márquez MP, Sainos A, Marfil J, Selva J, et al. Consenso de expertos en el uso terapéutico actual de la inmunoglobulina intravenosa. Rev Alerg Mex. 2005;52(1):42-50.
De la Vega VM, Rodríguez MG, Quintana MG. La disfunción endotelial: una propuesta hacia el cambio. Argentina: Intermedicina [Internet]; 2007. [Citado el 12 de octubre de 2012].
Saracco AS, De Roodt AR. Loxoscelismo. Revista Médica Universitaria. Facultad de Ciencias Médicas-UNCuyo. 2008;4(1):1-11.
Vetter RS, Bush SP. Additional considerations in presumptive brown recluse spider bites and dapsone therapy. Am J Emerg Med. 2004;22(6):494-5.
D’Suze G, Corzo-Burguete GA, Paniagua-Solís JF, editores. Emergencias por animales ponzoñosos en las Américas. México: Laboratorio Silanes; Instituto Bioclón; 2011.
Ramos-Cerrillo B, Olvera A, Odell GV, Zamudio F, Paniagua-Solís J, Alagón A. Genetic and enzymatic characterization of sphingomyelinase D isoforms from the North American fiddleback spiders Loxosceles boneti and Loxosceles reclusa. Toxicon. 2004;44(5):507-14.
Olvera A, Ramos-Cerrillo B, Estévez J, Clement H, de Roodt A, Paniagua-Solís J, et al. North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens. Toxicon. 2006;48(1):64-74.
De Roodt AR, García SI, Gómez CM, Estévez J, Alagón A, Gould EG, et al. Antitoxinas y antivenenos para uso terapéutico. Acta Toxicol Argent. 2004;12(2):29-41.
King LE, Ress RS. Dapsone treatment of a brown recluse bite. JAMA. 1983;250(5):648.
Bryant SM, Pittman LM. Dapsone use in Loxosceles reclusa envenomation: is there an indication? Am J Emerg Med. 2003;21(1):89-90.
Swanson DL, Vetter RS. Bites of brown recluse spiders and suspected necrotic arachnidism. N Engl J Med. 2005;352(7):700-7.
Joseph E, Hamori CA, Bergman S, Roaf E, Swann NF, Anastasi GW. A prospective, randomized trial of vacuum-assisted closure versus standard therapy of chronic non-healing wounds. Wounds. 2000;12(3):60-7.
Robledo-Ogazón F, Mier y Díaz J, Sánchez-Fernández P, Suárez-Moreno R, Vargas-Rivas A, Bojalil-Durán L. Uso del sistema de cierre asistido al vacío VAC® en el tratamiento de las heridas quirúrgicas infectadas. Experiencia clínica. Cir Cir. 2006; 74(2):107-13.
Rodriguez-Álvarez D, Sánchez-Villegas C. Refinements in loxoscelism treatment. Toxicology Letters. 2010;196(Suppl):S90.